Aspercreme with Lidocaine Essential Oils Rosemary Mint

Manufacturer
Chattem, Inc.
Effective date
2026-01-13
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
monthly-update
Hydrated at
2026-06-03 17:52:25

Label at a glance#

ProductAspercreme with Lidocaine Essential Oils Rosemary Mint
Active ingredientLIDOCAINE
Label structure8 sections

Dosage and administration

a dults and children over 12 years: ■ apply a thin layer to affected area not more than 3 to 4 times daily children 12 years or younger : ask a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

ASPERCREME LIDOCAINE WITH ROSEMARY MINT NO-MESS

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCl 4%

Purpose

OTC - PURPOSE SECTION

Topical anesthetic

Use

INDICATIONS & USAGE SECTION

temporarily relieves minor pain

Warnings

WARNINGS SECTION

For external use only

Do not use 

OTC - DO NOT USE SECTION

■ on large areas of the body or on cut, irritated or swollen skin

■ on puncture wounds 

■ for more than one week without consulting a doctor 

When using this product

OTC - WHEN USING SECTION

■ use only as directed. Read and follow all directions and warnings on this carton.

■ do not allow contact with the eyes and mucous membranes

■ do not bandage or apply local heat (such as heating pads) or a medicated patch to area of use

■ do not use at the same time as other topical analgesics  

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ condition worsens

■ redness is present

■ irritation develops

■ symptoms persist for more than 7 days or clear up and occur again within a few days

Flammable  ■ Keep away from fire or flame

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children over 12 years:

■ apply a thin layer to affected area not more than 3 to 4 times daily

children 12 years or younger: ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, methylparaben, polysorbate 60, rosemary mint fragrance, steareth-2, steareth-21, water

Child-resistant packaging. Close cap tightly after use.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAX STRENGTH
Aspercreme

with 4% LIDOCAINE

2.5 FL oz (73 mL)

MAX STRENGTH Aspercreme with 4% LIDOCAINE 2.5 FL oz (73 mL)MAX STRENGTH Aspercreme with 4% LIDOCAINE 2.5 FL oz (73 mL)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1987647lidocaine hydrochloride 4 % Topical SolutionPSN4
1987647lidocaine hydrochloride 40 MG/ML Topical SolutionSCD4
1987647lidocaine hydrochloride 4 % Topical SolutionSY4

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
070fbed5-7088-434a-a7ce-f2a64d8d40acProduct name220260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80fProduct name520250819
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57Product name320210602
aed701d5-9c75-dfaf-7154-cde46179faeaProduct name920200313
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508
49fa150c-f0de-cce7-3d9c-993ed81c5698Product name120140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ffProduct name120140508
9137811f-f279-8640-5aeb-99fa2145d64dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
41167-0598-7Aspercreme with Lidocaine Essential Oils Rosemary Mint1 in 1 CARTONLIQUID14
41167-0598-7Aspercreme with Lidocaine Essential Oils Rosemary Mint73 mL in 1 BOTTLE, WITH APPLICATORLIQUID734

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
41167-0598-7ML - Milliliter41167-0598028c5e60-e4df-45c5-9a8c-84d965cdae2012021-06-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41167-059841167-0598-7

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32023-10-24full-release2026-05-31 23:57:07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aspercreme with Lidocaine Essential Oils Rosemary MintLIDOCAINEChattem, Inc.9c81d5eb-fa9b-47fb-8924-6ebf6a5c6bab2026-01-13WarningsExact identifier
ndc (package): 41167-0598-7
ndc (product): 41167-0598
ndc11 (package): 41167059807
spl id: 755e8a1b-8e57-4429-968f-83444bcd5290
spl set id: 9c81d5eb-fa9b-47fb-8924-6ebf6a5c6bab

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.